Cabarron, Nila B.
HRN: 20-51-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2022
METRONIDAZOLE 500MG (TAB)
09/15/2022
09/18/2022
PO
500mg Tab
Tid
Infectious Diarrhea, Intraabdominal Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes